A Broad Safety Assessment of the Recombinant Herpes Zoster Vaccine
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Epidemiology"
DOI: 10.1093/aje/kwac030
Abstract: Abstract The recombinant herpes zoster vaccine (RZV), approved as a 2-dose series in the United States in October 2017, has proven highly effective and generally safe. However, a small risk of Guillain-Barré syndrome after vaccination… read more here.
Keywords: safety; recombinant herpes; zoster vaccine; herpes zoster ... See more keywords
Sequential Data-Mining for Adverse Events after Recombinant Herpes Zoster Vaccination Using the Tree-Based Scan Statistic.
Sign Up to like & getrecommendations! Published in 2022 at "American journal of epidemiology"
DOI: 10.1093/aje/kwac176
Abstract: Tree-based scan statistics have been successfully used to study the safety of several vaccines without prespecifying health outcomes of concern. In this study, the binomial tree-based scan statistic was applied sequentially to detect adverse events… read more here.
Keywords: tree based; recombinant herpes; vaccination; based scan ... See more keywords
Antibody Responses Following Primary Immunization with the Recombinant Herpes Zoster Vaccine (Shingrix®) in VZV Seronegative Immunocompromised Adults
Sign Up to like & getrecommendations! Published in 2025 at "Vaccines"
DOI: 10.3390/vaccines13070737
Abstract: Background: Immunocompromised patients are at risk of severe varicella zoster virus (VZV) infection and reactivation. In VZV seronegative immunocompromised persons, live-attenuated VZV vaccination is contraindicated, thus the recombinant herpes zoster vaccine (rHZV) remains a safe… read more here.
Keywords: recombinant herpes; vzv; herpes zoster; seronegative immunocompromised ... See more keywords